SaponiQx has announced successful production of STIMULON cpcQS-21, a cultured plant cell adjuvant with confirmed biochemical comparability to traditional bark extract-derived adjuvant. The company has submitted a Master File for STIMULON cpcQS-21 to the U.S. FDA for reference by partners as part of regulatory submissions. SaponiQx is also collaborating with Ginkgo Bioworks to drive innovation in its adjuvant pipeline through generative molecular design.